Effect of γ-secretase inhibitors on muscarinic receptor-mediated calcium signaling in human salivary epithelial cells

American Journal of Physiology - Cell Physiology

Volumn 291, Issue 1, 2006, Pages

  Oh, Young S ^a   Turner, R James ^a  

^a NATIONAL INSTITUTE OF DENTAL AND CRANIOFACIAL RESEARCH   (United States)

Author keywords

Alzheimer's disease; Carbachol; Inositol 1,4,5 trisphosphate; Presenilin

Indexed keywords

AMYLOID PRECURSOR PROTEIN; CALCIUM; CARBACHOL; GAMMA SECRETASE INHIBITOR; MUSCARINIC RECEPTOR; PRESENILIN 1; SMALL INTERFERING RNA; THAPSIGARGIN;

ARTICLE; CALCIUM SIGNALING; CALCIUM TRANSPORT; ENDOPLASMIC RETICULUM; ENZYME ACTIVITY; ENZYME INHIBITION; EPITHELIUM CELL; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; NULL CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; SALIVARY GLAND;

AMYLOID PRECURSOR PROTEIN SECRETASES; ANIMALS; ASPARTIC ENDOPEPTIDASES; CALCIUM; CALCIUM SIGNALING; CELL LINE; CELL LINE, TRANSFORMED; ENDOPEPTIDASES; EPITHELIAL CELLS; FIBROBLASTS; HUMANS; MICE; MICE, KNOCKOUT; PROTEASE INHIBITORS; RECEPTORS, MUSCARINIC; SALIVARY GLANDS;

EID: 33745728385     PISSN: 03636143     EISSN: 15221563     Source Type: Journal    
DOI: 10.1152/ajpcell.00508.2005     Document Type: Article

References (41)

1. Akbari Y, Hitt BD, Murphy MP, Dagher NN, Tseng BP, Green KN, Golde TE, and LaFerla FM. Presenilin regulates capacitative calcium entry dependently and independently of γ-secretase activity. Biochem Biophys Res Commun 322: 1145-1152, 2004.
2. Annaert W and De Strooper B. A cell biological perspective on Alzheimer's disease. Annu Rev Cell Dev Biol 18: 25-51, 2002.
3. Begley JG, Duan W, Chan S, Duff K, and Mattson MP. Altered calcium homeostasis and mitochondrial dysfunction in cortical synaptic compartments of presenilin-1 mutant mice. J Neurochem 72: 1030-1039, 1999.
4. Cedazo-Minguez A, Popescu BO, Ankarcrona M, Nishimura T, and Cowburn RF. The presenilin 1 ΔE9 mutation gives enhanced basal phospholipase C activity and a resultant increase in intracellular calcium concentrations. J Biol Chem 277: 36646-36655, 2002.
5. Dohke Y and Turner RJ. Evidence that the transmembrane biogenesis of aquaporin 1 is cotranslational in intact mammalian cells. J Biol Chem 277: 15215-15219, 2002.
6. Donoviel DB, Hadjantonakis AK, Ikeda M, Zheng H, Hyslop PS, and Bernstein A. Mice lacking both presenilin genes exhibit early embryonic patterning defects. Genes Dev 13: 2801-2810, 1999.
7. Dovey HF, John V, Anderson JP, Chen LZ, de Saint AP, Fang LY, Freedman SB, Folmer B, Goldbach E, Holsztynska EJ, Hu KL, Johnson-Wood KL, Kennedy SL, Kholodenko D, Knops JE, Latimer LH, Lee M, Liao Z, Lieberburg IM, Motter RN, Mutter LC, Nietz J, Quinn KP, Sacchi KL, Seubert PA, Shopp GM, Thorsett ED, Tung JS, Wu J, Yang S, Yin CT, Schenk DB, May PC, Altstiel LD, Bender MH, Boggs LN, Britton TC, Clemens JC, Czilli DL, Dieckman-McGinty DK, Droste JJ, Fuson KS, Gitter BD, Hyslop PA, Johnstone EM, Li WY, Little SP, Mabry TE, Miller FD, and Audia JE. Functional gamma-secretase inhibitors reduce beta-amyloid peptide levels in brain. J Neurochem 76: 173-181, 2001.
8. Esler WP, Kimberly WT, Ostaszewski BL, Ye W, Diehl TS, Selkoe DJ, and Wolfe MS. Activity-dependent isolation of the presenilin-γ-secretase complex reveals nicastrin and a γ substrate. Proc Natl Acad Sci USA 99: 2720-2725, 2002.
9. Etcheberrigaray R, Hirashima N, Nee L, Prince J, Govoni S, Racchi M, Tanzi RE, and Alkon DL. Calcium responses in fibroblasts from asymptomatic members of Alzheimer's disease families. Neurobiol Dis 5: 37-45, 1998.
10. Fortini ME. γ-Secretase-mediated proteolysis in cell-surface-receptor signalling. Nat Rev Mol Cell Biol 3: 673-684, 2002.
11. Fraser PE, Yang DS, Yu G, Levesque L, Nishimura M, Arawaka S, Serpell LC, Rogaeva E, and George-Hyslop P. Presenilin structure, function and role in Alzheimer's disease. Biochim Biophys Acta 1502: 1-15, 2000.
12. 2+ entry is associated with the familial Alzheimer's disease presenilin-2 T122R mutation and anticipates the onset of dementia. Neurobiol Dis 18: 638-648, 2005.
13. 2+ indicators with greatly improved fluorescence properties. J Biol Chem 260: 3440-3450, 1985.
14. Guo Q, Furukawa K, Sopher BL, Pham DG, Xie J, Robinson N, Martin GM, and Mattson MP. Alzheimer's PS-1 mutation perturbs calcium homeostasis and sensitizes PC12 cells to death induced by amyloid beta-peptide. Neuroreport 8: 379-383, 1996.
15. Hayashi Y, Yanagawa T, Yoshida H, Azuma M, Nishida T, Yura Y, and Sato M. Expression of vasoactive intestinal polypeptide and amylase in a human parotid gland adenocarcinoma cell line in culture. J Natl Cancer Inst 79: 1025-1037, 1987.
16. Herms J, Schneider I, Dewachter I, Caluwaerts N, Kretzschmar H, and Van Leuven F. Capacitive calcium entry is directly attenuated by mutant presenilin-1, independent of the expression of the amyloid precursor protein. J Biol Chem 278: 2484-2489, 2003.
17. 2+ mobilization is altered in fibroblasts from patients with Alzheimer's disease. Proc Natl Acad Sci USA 91: 534-538, 1994.
18. Kopan R and Ilagan MX. γ-Secretase: proteasome of the membrane? Nat Rev Mol Cell Biol 5: 499-504, 2004.
19. LaFerla FM. Calcium dyshomeostasis and intracellular signalling in Alzheimer's disease. Nat Rev Neurosci 3: 862-872, 2002.
20. Leissring MA, Akbari Y, Fanger CM, Cahalan MD, Mattson MP, and LaFerla FM. Capacitative calcium entry deficits and elevated luminal calcium content in mutant presenilin-1 knockin mice. J Cell Biol 149: 793-798, 2000.
21. Leissring MA, LaFerla FM, Callamaras N, and Parker I. Subcellular mechanisms of presenilin-mediated enhancement of calcium signaling. Neurobiol Dis 8: 469-478, 2001.
22. Leissring MA, Murphy MP, Mead TR, Akbari Y, Sugarman MC, Jannatipour M, Anliker B, Muller U, Saftig P, De SB, Wolfe MS, Golde TE, and LaFerla FM. A physiologic signaling role for the γ-secretase-derived intracellular fragment of APP. Proc Natl Acad Sci USA 99: 4697-4702, 2002.
23. Leissring MA, Parker I, and LaFerla FM. Presenilin-2 mutations modulate amplitude and kinetics of inositol 1,4,5-trisphosphate-mediated calcium signals. J Biol Chem 274: 32535-32538, 1999.
24. Leissring MA, Paul BA, Parker I, Cotman CW, and LaFerla FM. Alzheimer's presenilin-1 mutation potentiates inositol 1,4,5-trisphosphate-mediated calcium signaling in Xenopus oocytes. J Neurochem 72: 1061-1068, 1999.
25. Meredith JE Jr, Wang Q, Mitchell TJ, Olson RE, Zaczek R, Stern AM, and Seiffert D. γ-Secretase activity is not involved in presenilin-mediated regulation of β-catenin. Biochem Biophys Res Commun 299: 744-750, 2002.
26. Oberdorf J, Webster JM, Zhu CC, Luo SG, and Wojcikiewicz RJ. Down-regulation of types I, II and III inositol 1,4,5-trisphosphate receptors is mediated by the ubiquitin/proteasome pathway. Biochem J 339: 453-461, 1999.
27. Popescu BO, Cedazo-Minguez A, Benedikz E, Nishimura T, Winblad B, Ankarcrona M, and Cowburn RF. γ-Secretase activity of presenilin 1 regulates acetylcholine muscarinic receptor-mediated signal transduction. J Biol Chem 279: 6455-6464, 2004.
28. Schneider I, Reverse D, Dewachter I, Ris L, Caluwaerts N, Kuiperi C, Gilis M, Geerts H, Kretzschmar H, Godaux E, Moechars D, Van LF, and Herms J. Mutant presenilins disturb neuronal calcium homeostasis in the brain of transgenic mice, decreasing the threshold for excitotoxicity and facilitating long-term potentiation. J Biol Chem 276: 11539-11544, 2001.
29. Seiffert D, Bradley JD, Rominger CM, Rominger DH, Yang F, Meredith JE Jr, Wang Q, Roach AH, Thompson LA, Spitz SM, Higaki JN, Prakash SR, Combs AP, Copeland RA, Arneric SP, Hartig PR, Robertson DW, Cordell B, Stern AM, Olson RE, and Zaczek R. Presenilin-1 and -2 are molecular targets for γ-secretase inhibitors. J Biol Chem 275: 34086-34091, 2000.
30. Selkoe DJ. Alzheimer's disease: genes, proteins, and therapy. Physiol Rev 81: 741-766, 2001.
31. Ship JA, DeCarli C, Friedland RP, and Baum BJ. Diminished submandibular salivary flow in dementia of the Alzheimer's type. J Gerontol 45: M61-M66, 1990.
32. Shirasuna K, Sato M, and Miyazaki T. A neoplastic epithelial duct cell line established from an irradiated human salivary gland. Cancer 48: 745-752, 1981.
33. Sipma H, Deelman L, Smedt HD, Missiaen L, Parys JB, Vanlingen S, Henning RH, and Casteels R. Agonist-induced down-regulation of type 1 and type 3 inositol 1,4,5-trisphosphate receptors in A7r5 and DDT1 MF-2 smooth muscle cells. Cell Calcium 23: 11-21, 1998.
34. 3 signaling, and Alzheimer's disease. Neuroscientist 11: 110-115, 2005.
35. 2+ signals and altered membrane excitability. J Neurosci 24: 508-513, 2004.
36. Thinakaran G and Parent AT. Identification of the role of presenilins beyond Alzheimer's disease. Pharmacol Res 50: 411-418, 2004.
37. Van Gassen G and Annaert W. Amyloid, presenilins, and Alzheimer's disease. Neuroscientist 9: 117-126, 2003.
38. Wojcikiewicz RJ, Furuichi T, Nakade S, Mikoshiba K, and Nahorski SR. Muscarinic receptor activation down-regulates the type I inositol 1,4,5-trisphosphate receptor by accelerating its degradation. J Biol Chem 269: 7963-7969, 1994.
39. Yoo AS, Cheng I, Chung S, Grenfell TZ, Lee H, Pack-Chung E, Handler M, Shen J, Xia W, Tesco G, Saunders AJ, Ding K, Frosch MP, Tanzi RE, and Kim TW. Presenilin-mediated modulation of capacitative calcium entry. Neuron 27: 561-572, 2000.
40. 2+ release from intracellular stores. Neurobiol Dis 15: 269-278, 2004.
41. Zhang Z, Nadeau P, Song W, Donoviel D, Yuan M, Bernstein A, and Yankner BA. Presenilins are required for γ-secretase cleavage of β-APP and transmembrane cleavage of Notch-1. Nat Cell Biol 2: 463-465, 2000.